🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Single agent, non-randomized, open label expansion in select sarcoma patien...
Status
Unknown
Location
Children's Hospital Los Angeles
Start Date
2018-06-04
Trial ID
NCT03600649
Treatments Being Tested
This phase I/II trial identifies the best dose of seclidemstat when given t...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-07-07
Trial ID
NCT04734990
Treatments Being Tested
Phase 1, open-label, non-randomized dose finding study of SP-2577 in patien...
Status
Completed
Location
HonorHealth
Start Date
2019-06-25
Trial ID
NCT03895684
Treatments Being Tested
This rollover protocol allows continued access to seclidemstat (SP-2577) fo...
Status
Unknown
Location
Sarcoma Oncology Center
Start Date
2022-01-15
Trial ID
NCT05266196
Treatments Being Tested
Open-label study of SF-2577 plus pembrolizumab in advanced, recurrent small...
Status
Withdrawn
Location
HonorHealth Research Institute
Start Date
2021-12-31
Trial ID
NCT04611139
Treatments Being Tested